A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00168480

Enrollment

424

Registered

2005-09-15

Start date

2003-11-30

Completion date

2007-04-30

Last updated

2008-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperhidrosis

Brief summary

This is a three year open-label study in subjects with axillary hyperhidrosis.

Interventions

BIOLOGICALBotulinum Toxin Type A

100 U, repeated treatments at \> 4 month intervals up to Month 32, over a 36-month study period

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Marked axillary hyperhidrosis

Exclusion criteria

* Previous use of botulinum toxin for hyperhidrosis

Design outcomes

Primary

Measure	Time frame
Assessment of axillary sweat production	Every 4 Months

Secondary

Measure	Time frame
Patient reported health outcome measures	1 Month Post-Treatment Visit

Countries

Germany, Sweden, United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026